⌘K

Login Start Free

Home/Filings/4/0001209191-08-031568

4//SEC Filing

IDERA PHARMACEUTICALS, INC. 4

Accession 0001209191-08-031568

CIK 0000861838operating

View on SEC.gov Company Profile

Filed

May 19, 8:00 PM ET

Accepted

May 20, 9:47 AM ET

Size

14.0 KB

Accession

0001209191-08-031568

Insider Transaction Report

Form 4

Period: 2008-05-16

IDERA PHARMACEUTICALS, INC.IDRA

WYNGAARDEN JAMES B

Director

Transactions

Exercise/Conversion
Common Stock
2008-05-16$4.00/sh+1,000$4,000→ 37,685 total
Sale
Common Stock
2008-05-16$14.79/sh−1,000$14,790→ 36,685 total
Exercise/Conversion
Common Stock
2008-05-16$4.00/sh+4,990$19,960→ 41,675 total
Exercise/Conversion
Stock Options
2008-05-16−1,000→ 0 total
Exercise: $4.00From: 2000-06-08Exp: 2009-06-08→ Common Stock (1,000 underlying)
Sale
Common Stock
2008-05-16$14.79/sh−4,990$73,802→ 36,685 total
Exercise/Conversion
Stock Options
2008-05-16−4,990→ 0 total
Exercise: $4.00From: 2001-03-01Exp: 2009-05-17→ Common Stock (4,990 underlying)

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

IDERA PHARMACEUTICALS, INC.

CIK 0000861838

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0000861838

Filing Metadata

Form type: 4
Filed: May 19, 8:00 PM ET
Accepted: May 20, 9:47 AM ET
Size: 14.0 KB

View on SEC.gov